Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?

Ingrid Fricke-GalindoRamcés Falfan-Valencia

Published in: Expert review of respiratory medicine (2022)

The pharmacogenomics recommendations for lung diseases are limited. The clinical implementation of pharmacogenomics in treating respiratory diseases will contribute to the quality of life of patients with chronic respiratory diseases.

Keyphrases

primary care
healthcare
clinical decision support
quality improvement
clinical practice
respiratory tract
adverse drug
electronic health record